---
category: news
title: "HitGen taps Cambridge Molecular for 'deep learning' drug discovery collab"
excerpt: "Chinese drug discovery biotech HitGen is teaming up with U.K.-based Cambridge Molecular to better seek out new drugs. The pair has penned an exclusive alliance, financials of which were not shared, to create the so-called DeepDELve 2 – Cambridge Molecular’s highly optimized DNA encoded library (DEL)-specific deep learning system,"
publishedDateTime: 2021-11-05T12:30:00Z
originalUrl: "https://www.fiercebiotech.com/biotech/hitgen-taps-cambridge-molecular-for-deep-learning-drug-discovery-collab"
webUrl: "https://www.fiercebiotech.com/biotech/hitgen-taps-cambridge-molecular-for-deep-learning-drug-discovery-collab"
type: article
quality: 38
heat: 38
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1636111353/Screen%20Shot%202020-05-21%20at%208.40.18%20AM.png/Screen%20Shot%202020-05-21%20at%208.40.18%20AM.png?VersionId=O6e7OPPJADm3ZW8sZjKvlaxWYHW8rhTG"
    width: 682
    height: 400
    isCached: true

related:
  - title: "HitGen and Cambridge Molecular announce a strategic partnership, bringing together DNA-Encoded Libraries and Deep Learning"
    excerpt: "HitGen Inc. (688222.SH) and Cambridge Molecular are pleased to announce an exclusive alliance, introducing DeepDELve 2 – Cambridge Molecular’s highly optimised DEL-specific deep learning system – as an addition to HitGen’s world-leading DEL discovery platform,"
    publishedDateTime: 2021-11-05T02:02:00Z
    webUrl: "https://apnews.com/press-release/BusinessWire/science-technology-business-england-chengdu-cfb6a4f760bf41ac86b04dbb91e5f144"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 13
    images:
      - url: "https://apnews.com/images/PaidContent3.png"
        width: 700
        height: 450
        isCached: true

secured: "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;Qo7gC11s3959gnXw7u/Bsw=="
---

